Fidson Healthcare

Fidson Healthcare EBITDA per Employee

The EBITDA per Employee of Fidson Healthcare (FIDSON.NL) as of Nov 2, 2026 is 32.45 M NGN. In the previous year, EBITDA per Employee was 16.43 M NGN — a change of 97.46% (higher).

EBITDA per Employee

32.45 MNGN

YoY

97.46%

Last updated:

EBITDA per Employee of Fidson Healthcare is 2024 32.45 M NGN. EBITDA per Employee of Fidson Healthcare was 2023 16.43 M NGN. It decreases by 97.46% higher compared to the previous year.

The Fidson Healthcare EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2017
4.72 M NGN
Jan 1, 2018
3.92 M NGN
Jan 1, 2019
4.24 M NGN
Jan 1, 2020
5.74 M NGN
Jan 1, 2021
13.98 M NGN
Jan 1, 2022
14.54 M NGN
Jan 1, 2023
16.43 M NGN
Jan 1, 2024
32.45 M NGN
The Fidson Healthcare EBITDA per Employee history
YEAREBITDA per EmployeeYoY
32.45 MNGN+97.46%
16.43 MNGN+13.05%
14.54 MNGN+4.02%
13.98 MNGN+143.53%
5.74 MNGN+35.35%
4.24 MNGN+8.16%
3.92 MNGN-16.90%
4.72 MNGN+112.30%
2.22 MNGN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fidson Healthcare Stock analysis

What does Fidson Healthcare do? Fidson Healthcare Plc manufactures and distributes pharmaceutical products, including drugs, infusion and injectables, across its segments: over-the-counter, ethical products, and consumer. The over-the-counter segment sells products directly to consumers without prescriptions, while the ethical products segment offers prescription-only drugs, injectables, and infusions. The consumer segment focuses on household items. The company provides formulation/development, contract manufacturing, and production services for medicines. Its product portfolio includes Anti Infective & Anti Malaria, Central Nervous System (CNS), Gastrointestinal Medicines, Supplements, Topical/Dermatological Medicines, Vitamins & Minerals, Ophthalmic Solution, and others, with Ophthalmic Solution specifically targeting eye conditions. The company's primary revenue streams come from the sale of pharmaceutical products within its three segments. Over-the-counter products are purchased by general consumers, ethical products are bought by healthcare providers and pharmacies requiring prescriptions, and consumer segment items are sold to households. Fidson Healthcare Plc serves the Nigerian market through its manufacturing and distribution network, leveraging its full-time workforce of 593 employees to support operations. Fidson Healthcare Plc's product lines are tailored to specific market needs, with Anti Infective & Anti Malaria products addressing infectious diseases, CNS medications targeting neurological disorders, and Ophthalmic Solution treating eye conditions. The company's services in formulation/development and contract manufacturing further generate revenue by supporting other pharmaceutical firms in product creation and production. Fidson Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fidson Healthcare stock

EBITDA per Employee of Fidson Healthcare is 32.45 M NGN in 2024.

EBITDA per Employee of Fidson Healthcare changed from 16.43 M NGN to 32.45 M NGN, representing a 97.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Fidson Healthcare since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's NGN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Fidson Healthcare historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Fidson Healthcare

All Key Metrics — Fidson Healthcare